Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Multi-carrier operation for wireless systems
Compositions and processes for forming photovoltaic devices
Method and apparatus for internet on-line insurance policy service
Multi currency exchanges between participants
Systems, methods, and media for firewall control via remote system information
Method and apparatus for secure transfer and playback of multimedia content
Electronic system auto-mute control circuit and control method thereof
  Randomly Featured Patents
System and method for profiling processes in a computing system
Derivatives of 5-pentylamino-5-oxopentanoil and 4-pentlamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin
Lcd panel production
Tire track
Dichloroacyl diphenyl ether mite ovacides
Apparatus for the treatment of plastic materials
Triangle coverage estimation and edge-correct tessellation
Information processing apparatus and information processing method for determining character layout
Programmable mapping of external requestors to privilege classes for access protection
Packaging container for an electrical switch